American International Group, Inc. Rhythm Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 26,318 shares of RYTM stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,318

Previous 25,537 3.06%

Holding current value

$1.08 Million

Previous $1.17 Million 2.81%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$39.12 - $52.44 $30,552 - $40,955	781 Added 3.06%	26,318 $1.14 Million
Q4 2023 Feb 13, 2024	SELL	$21.39 - $49.64 $2,203 - $5,112	-103 Reduced 0.4%	25,537 $1.17 Million
Q3 2023 Nov 13, 2023	BUY	$15.81 - $27.8 $14,402 - $25,325	911 Added 3.68%	25,640 $587,000
Q2 2023 Aug 04, 2023	BUY	$16.32 - $21.15 $403,577 - $523,018	24,729 New	24,729 $407,000
Q2 2022 Aug 12, 2022	SELL	$3.12 - $12.25 $68,237 - $267,919	-21,871 Closed	0 $0

Q1 2022 May 13, 2022	SELL	$6.13 - $12.24 $9,440 - $18,849	-1,540 Reduced 6.58%	21,871 $252,000
Q4 2021 Feb 11, 2022	SELL	$8.62 - $13.9 $6,033 - $9,730	-700 Reduced 2.9%	23,411 $234,000
Q3 2021 Nov 12, 2021	SELL	$11.68 - $20.72 $6,692 - $11,872	-573 Reduced 2.32%	24,111 $315,000
Q2 2021 Aug 13, 2021	BUY	$18.52 - $22.55 $45,781 - $55,743	2,472 Added 11.13%	24,684 $483,000
Q1 2021 May 07, 2021	BUY	$20.25 - $39.49 $54,067 - $105,438	2,670 Added 13.66%	22,212 $472,000
Q4 2020 Feb 12, 2021	SELL	$21.17 - $32.61 $11,834 - $18,228	-559 Reduced 2.78%	19,542 $581,000
Q3 2020 Nov 04, 2020	SELL	$18.13 - $30.61 $8,303 - $14,019	-458 Reduced 2.23%	20,101 $436,000
Q2 2020 Aug 12, 2020	BUY	$14.41 - $25.35 $46,241 - $81,348	3,209 Added 18.5%	20,559 $458,000
Q1 2020 May 04, 2020	SELL	$13.16 - $22.9 $13,199 - $22,968	-1,003 Reduced 5.47%	17,350 $264,000
Q4 2019 Feb 05, 2020	BUY	$19.53 - $25.5 $75,112 - $98,073	3,846 Added 26.51%	18,353 $421,000
Q3 2019 Nov 08, 2019	SELL	$18.62 - $24.51 $1,880 - $2,475	-101 Reduced 0.69%	14,507 $313,000
Q2 2019 Aug 13, 2019	BUY	$21.11 - $28.48 $103,460 - $139,580	4,901 Added 50.49%	14,608 $321,000
Q1 2019 May 06, 2019	SELL	$24.76 - $31.66 $7,774 - $9,941	-314 Reduced 3.13%	9,707 $266,000
Q4 2018 Feb 13, 2019	SELL	$24.11 - $31.34 $1,856 - $2,413	-77 Reduced 0.76%	10,021 $269,000
Q3 2018 Nov 09, 2018	BUY	$26.99 - $35.85 $57,056 - $75,786	2,114 Added 26.48%	10,098 $295,000
Q2 2018 Aug 08, 2018	BUY	$17.02 - $35.2 $46,277 - $95,708	2,719 Added 51.64%	7,984 $250,000
Q1 2018 May 07, 2018	SELL	$19.9 - $32.25 $5,651 - $9,159	-284 Reduced 5.12%	5,265 $105,000
Q4 2017 Feb 09, 2018	BUY	$22.0 - $30.51 $122,078 - $169,299	5,549	5,549 $161,000

Others Institutions Holding RYTM

# of Institutions

176

Shares Held

62.4M

Call Options Held

880K

Put Options Held

84.1K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.29B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Rhythm Pharmaceuticals, Inc. Transaction History